EMILY FRANCIS: Open Payments
NPI 1659934396 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,181 in 247 payments from 20 companies in 2025. Trend: 2023 $3,424 · 2024 $2,882 · 2025 $6,181
Food & beverage: $5,838Education: $343
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 41 | $1,135 |
| ABBVIE INC. | 46 | $845 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $686 |
| Janssen Biotech, Inc. | 16 | $573 |
| GENZYME CORPORATION | 4 | $372 |
| UCB, Inc. | 10 | $361 |
| Lilly USA, LLC | 16 | $295 |
| Novartis Pharmaceuticals Corporation | 14 | $253 |
| Botanix SB Inc | 9 | $251 |
| Arcutis Biotherapeutics, Inc. | 7 | $241 |
Products named: NEMLUVIO, TREMFYA, DUPIXENT, SKYRIZI, ILUMYA, AKLIEF, Bimzelx, RINVOQ.
Industry payments across FL — which companies pay providers there.
